Cargando…

Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes

OBJECTIVES: To describe the development process for defining an appropriate model structure for the economic evaluation of test–treatment strategies for patients with monogenic diabetes (caused by mutations in the GCK, HNF1A or HNF4A genes). DESIGN: Experts were consulted to identify and define real...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Jaime L, Anderson, Rob, Hyde, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657677/
https://www.ncbi.nlm.nih.gov/pubmed/23793674
http://dx.doi.org/10.1136/bmjopen-2013-002905
_version_ 1782270163129729024
author Peters, Jaime L
Anderson, Rob
Hyde, Chris
author_facet Peters, Jaime L
Anderson, Rob
Hyde, Chris
author_sort Peters, Jaime L
collection PubMed
description OBJECTIVES: To describe the development process for defining an appropriate model structure for the economic evaluation of test–treatment strategies for patients with monogenic diabetes (caused by mutations in the GCK, HNF1A or HNF4A genes). DESIGN: Experts were consulted to identify and define realistic test–treatment strategies and care pathways. A systematic assessment of published diabetes models was undertaken to inform the model structure. SETTING: National Health Service in England and Wales. PARTICIPANTS: Experts in monogenic diabetes whose collective expertise spans the length of the patient care pathway. PRIMARY AND SECONDARY OUTCOMES: A defined model structure, including the test–treatment strategies, and the selection of a published diabetes model appropriate for the economic evaluation of strategies to identify patients with monogenic diabetes. RESULTS: Five monogenic diabetes test–treatment strategies were defined: no testing of any kind, referral for genetic testing based on clinical features as noted by clinicians, referral for genetic testing based on the results of a clinical prediction model, referral for genetic testing based on the results of biochemical and immunological tests, referral for genetic testing for all patients with a diagnosis of diabetes under the age of 30 years. The systematic assessment of diabetes models identified the IMS CORE Diabetes Model (IMS CDM) as a good candidate for modelling the long-term outcomes and costs of the test–treatment strategies for monogenic diabetes. The short-term test–treatment events will be modelled using a decision tree which will feed into the IMS CDM. CONCLUSIONS: Defining a model structure for any economic evaluation requires decisions to be made. Expert consultation and the explicit use of critical appraisal can inform these decisions. Although arbitrary choices have still been made, decision modelling allows investigation into such choices and the impact of assumptions that have to be made due to a lack of data.
format Online
Article
Text
id pubmed-3657677
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-36576772013-05-21 Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes Peters, Jaime L Anderson, Rob Hyde, Chris BMJ Open Health Services Research OBJECTIVES: To describe the development process for defining an appropriate model structure for the economic evaluation of test–treatment strategies for patients with monogenic diabetes (caused by mutations in the GCK, HNF1A or HNF4A genes). DESIGN: Experts were consulted to identify and define realistic test–treatment strategies and care pathways. A systematic assessment of published diabetes models was undertaken to inform the model structure. SETTING: National Health Service in England and Wales. PARTICIPANTS: Experts in monogenic diabetes whose collective expertise spans the length of the patient care pathway. PRIMARY AND SECONDARY OUTCOMES: A defined model structure, including the test–treatment strategies, and the selection of a published diabetes model appropriate for the economic evaluation of strategies to identify patients with monogenic diabetes. RESULTS: Five monogenic diabetes test–treatment strategies were defined: no testing of any kind, referral for genetic testing based on clinical features as noted by clinicians, referral for genetic testing based on the results of a clinical prediction model, referral for genetic testing based on the results of biochemical and immunological tests, referral for genetic testing for all patients with a diagnosis of diabetes under the age of 30 years. The systematic assessment of diabetes models identified the IMS CORE Diabetes Model (IMS CDM) as a good candidate for modelling the long-term outcomes and costs of the test–treatment strategies for monogenic diabetes. The short-term test–treatment events will be modelled using a decision tree which will feed into the IMS CDM. CONCLUSIONS: Defining a model structure for any economic evaluation requires decisions to be made. Expert consultation and the explicit use of critical appraisal can inform these decisions. Although arbitrary choices have still been made, decision modelling allows investigation into such choices and the impact of assumptions that have to be made due to a lack of data. BMJ Publishing Group 2013-05-15 /pmc/articles/PMC3657677/ /pubmed/23793674 http://dx.doi.org/10.1136/bmjopen-2013-002905 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode
spellingShingle Health Services Research
Peters, Jaime L
Anderson, Rob
Hyde, Chris
Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes
title Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes
title_full Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes
title_fullStr Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes
title_full_unstemmed Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes
title_short Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes
title_sort development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes
topic Health Services Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657677/
https://www.ncbi.nlm.nih.gov/pubmed/23793674
http://dx.doi.org/10.1136/bmjopen-2013-002905
work_keys_str_mv AT petersjaimel developmentofaneconomicevaluationofdiagnosticstrategiesthecaseofmonogenicdiabetes
AT andersonrob developmentofaneconomicevaluationofdiagnosticstrategiesthecaseofmonogenicdiabetes
AT hydechris developmentofaneconomicevaluationofdiagnosticstrategiesthecaseofmonogenicdiabetes